MORE►
Prime Movers Lab
Amy Kruse is general partner and chief investment officer at Satori Neuro. [Photo: Satori Capital]
Satori Capital Raises $10.3M for Satori Neuro Fund, Following Mental Health Venture Launch
by Quincy Preston | May 16, 2023
The funding builds on the Dallas-based investment firm's launch of Satori Neuro in February. Managing Partner and Chief Investment Officer Dr. Amy Kruse will identify and seize opportunities that address “the world’s most critical mental health challenges."
by David Seeley |
Feb 2, 2023
The new venture will be led by Managing Partner and Chief Investment Officer Dr. Amy Kruse. It will seek opportunities in innovative therapeutics including psychedelic medicine, brainwave devices, VR and AR protocols, and more.
“We've learned more about the human brain in the last five years than we previously learned in the last 50—and that knowledge is rapidly transforming into real-world applications," Kruse says.
MORE►
